search
IBRX
Trends
- 1ImmunityBio Stock Under Pressure as Retail Buyers Call It Cheap●IBRX Stock Under Pressure: Retail Sees 'Ridiculously Cheap' Bargain As Founder Touts Sister Firm NantIQ's Aetna Work
ImmunityBio (IBRX) shares are under pressure, but retail investors are calling the stock 'ridiculously cheap' and viewing the dip as a buying opportunity. Attention has also turned to founder Patrick Soon-Shiong, who is promoting the work of his sister company NantIQ with insurer Aetna, a move some see as a distraction from IBRX's own struggles.